12 February 2025 - We’ve partnered with the US based ICER and the Canadian Drug Agency (CDA-AMC) to establish the Health ...
20 January 2025 - IQWiG welcomes the fact that the adjustments to the AMNOG procedure planned for the integration with European ...
17 January 2025 - Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits ...
12 December 2024 - The results from EUnetHTA 21 provide insights for future cooperation in EU-HTA: participants from IQWiG and ...
15 May 2024 - At the end of April 2024, Mao-Ting Sheen visited the Institute for Quality and Efficiency in Healthcare ...
18 March 2024 - A consumer-led Co-design Working Group has developed proposed recommendations for enhancing consumer engagement processes to enable ...
1 March 2024 - A few months before the EU HTA regulation came into force, a delegation from the French HTA ...
1 February 2024 - On 19 December 2023, we advised that NICE would be liaising with key stakeholders to determine ...
25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...
20 October 2023 - The objective was to identify and describe the published guidance and current academic discourse of ethical issues ...
20 September 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada ...
24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...
8 August 2023 - While patient participation in individual health technology assessments has been frequently described in the literature, patient and ...
20 July 2023 - PHARMAC has joined an international collaboration of government health technology assessment agencies. ...
24 April 2023 - NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and ...